Can You Get Pregnant With PCOS? The Actual Conception Rates

Can a Woman With PCOS Get Pregnant?

Sixty percent of women with anovulatory PCOS conceived within 12 months of starting ovulation induction, and that figure rose to 78% by 24 months, in a cohort of 108 treatment-naive women with PCOS followed at a Dutch tertiary infertility clinic. That is the plain answer to whether the diagnosis itself blocks pregnancy: it does not, for most people.

PCOS is the single most common cause of anovulatory infertility — irregular or absent ovulation, not a broken reproductive system. The ovaries in PCOS typically still contain eggs and still respond to hormonal signals; what usually goes wrong is the monthly release. That distinction is why “can a PCOS woman get pregnant,” “can you still get pregnant with PCOS,” and “can PCOS people get pregnant” all have the same answer: yes, and treatment that restores ovulation is usually the lever that works, not a lever that doesn’t exist.

Note: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. Same condition, same reproductive mechanism — only the label changed. This article uses PCOS, since that is still the term most readers search.

Is It Hard to Get Pregnant With PCOS?

In a Dutch cohort of 1,779 women newly diagnosed with PCOS, 37% conceived a pregnancy that reached term within the first year after diagnosis, following a standardized ovulation-induction protocol. For comparison, a German study of 346 women without a diagnosed fertility problem, using timed intercourse from their first cycle onward, found a 92% cumulative probability of conception within 12 cycles. Set side by side, that gap is the honest answer to “is it hard to get pregnant with PCOS” — yes, on average, and the right word is “harder,” not “impossible.”

The mechanism behind the slowdown is cycle frequency, not egg quality. Anovulation means fewer fertile cycles occur per year, sometimes far fewer, so there are simply fewer chances to conceive in any given twelve-month window. When ovulation does happen — spontaneously or with treatment — the odds of conceiving in that specific cycle are not automatically lower than in a woman without PCOS. That is also why “does PCOS make it hard to get pregnant” and “how hard is it to get pregnant with PCOS” are really questions about cycle frequency, and why restoring regular ovulation is where treatment concentrates its effort.

The same German data point to something else worth knowing: the couples who eventually conceived showed a far flatter age-related decline than the group as a whole, because that subgroup was more biologically homogeneous to begin with. PCOS changes the shape of that curve by making a portion of cycles anovulatory outright rather than just less fertile — which is a mechanical problem with mechanical fixes, not a verdict on egg quality or a countdown that only moves in one direction.

What Do the Actual Numbers Say?

Four cohorts, each measuring something different about fertility with PCOS, put a real number on the question instead of a reassurance.

Read together, these tell a consistent story. In treatment-seeking cohorts, more than half of women conceive within one to two years of starting ovulation induction. In the unselected population data — women followed for 25 years regardless of whether they ever sought fertility treatment — 77% of women with PCOS had given birth to at least one child by their mid-forties, against 82% of women without PCOS. That is a real gap, worth taking seriously, and also proof that “PCOS pregnancy” is the outcome for most people who have the diagnosis, not the exception.

It also explains why a single number never satisfactorily answers “fertility with PCOS” as a search query. A woman asking that question three months into trying is really asking about the treatment-cohort numbers — the 37%, the 60–78% range. A woman asking it as a general life question about whether PCOS will let her have a family at all is better served by the population number — the 77% versus 82%. Both are real answers to real versions of the same question, and neither one is the whole picture on its own.

Who Faces Genuinely Lower Odds, and Why

Every extra year a PCOS diagnosis is delayed nearly doubles the odds of a first birth at an advanced maternal age — an adjusted odds ratio of 1.98 — in the same Australian cohort of 981 women with PCOS followed from ages 18–23 to 43–48. Timing, not the syndrome itself, drives a real share of the gap between PCOS and non-PCOS fertility outcomes.

The Dutch nomogram study found the same pattern from a different angle: race, smoking status, body mass index, fasting insulin, testosterone, and SHBG concentration all independently predicted whether a woman conceived within her first year of treatment. Higher BMI, higher insulin, and higher testosterone lowered the odds; higher SHBG raised them. None of this is about effort or personal choices — it is measurable physiology, and it means the honest answer to “chances of getting pregnant with PCOS” is phenotype-dependent, not one number for everyone.

That split runs along the same lines that separate PCOS phenotypes more broadly. In the insulin- resistant pattern, higher circulating insulin drives ovarian androgen production and lowers SHBG, which is part of why this group shows up disproportionately in the “lower odds” data above. Lean PCOS carries a different metabolic profile — normal or low BMI, often normal insulin — and while anovulation is just as real, the BMI-linked predictors in the nomogram above do not apply the same way. Neither phenotype is diagnosed with a different treatment path by default, but the mechanism behind the anovulation differs, and that is worth knowing before assuming one story fits every PCOS diagnosis.

None of the predictors above are fixed facts about a person — they are the variables a clinician actually weighs when estimating an individual timeline, which is different from a population average. A 27-year-old with a lower BMI and a recent diagnosis is working from a materially better starting position in these cohorts than a 38-year-old whose PCOS went undiagnosed for a decade, even though both carry the same diagnosis label. That is also the honest limit of this article: population data describes where the odds cluster, not what will happen to one specific cycle.

What Actually Improves the Odds

Restoring ovulation is what the evidence above is measuring, and the 2023 international PCOS guideline frames three things as worth raising with a clinician, in roughly this order: confirming whether and when ovulation is actually happening, addressing modifiable metabolic factors where they apply, and using an ovulation-induction medication if cycles remain anovulatory.

Confirming ovulation matters more than it sounds like it should, because standard over-the-counter tools are unreliable in PCOS for a specific, mechanical reason — covered in full here — and treatment decisions built on a false signal waste cycles rather than saving them. Where BMI and insulin resistance are part of the picture, modest changes to that metabolic profile are associated with more spontaneous ovulation in some studies, though the guideline is clear this is a contributor, not a cure, and results vary by how insulin-resistant the underlying phenotype is. Where ovulation does not resume, medication is the guideline’s next recommended step — clomiphene and letrozole are compared head-to-head here, including why the guideline’s first choice changed. None of this is a sequence to run alone; it is a list of questions to bring to a clinician who can check which one applies to your case.

A baseline fertility work-up for both partners is also standard practice before any of this starts, not an optional extra layered on afterward. The Legro 2014 trial only enrolled women who already had a documented patent fallopian tube, a normal uterine cavity, and a partner with a sperm concentration of at least 14 million per millilitre — a reminder that “PCOS” being the diagnosis on paper does not rule out a second, unrelated factor also being in play. A clinician checking tubal patency and a semen analysis alongside the PCOS-specific work-up is standard practice, not a sign that something else is assumed to be wrong.

This same combination of questions — confirm ovulation, address what’s modifiable, escalate to medication if needed — is the backbone of the fertility guidance covered across this site, not a shortcut specific to this page.

When to See a Fertility Specialist

Common questions